| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |